Kyoto, Japan

Tadatsugu Harukawa

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadatsugu Harukawa. Retrieved from https://idiyas.com/inventor/tadatsugu-harukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tadatsugu Harukawa

Introduction

Tadatsugu Harukawa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of antibacterial agents, particularly through his innovative patent. His work is recognized for its potential impact on healthcare and medicine.

Latest Patents

Harukawa holds a patent for 6-(1'-Cyclohexenylglycinamido)penicillanic acid and salts thereof. This compound exhibits both a broad spectrum antibacterial action and strong activity against Escherichia coli. His invention is a testament to his dedication to advancing medical science and improving treatment options.

Career Highlights

Tadatsugu Harukawa is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His role at Takeda has allowed him to collaborate with other talented professionals in the industry. His contributions have been instrumental in the development of new antibacterial therapies.

Collaborations

Some of his notable coworkers include Tsunehiko Asako and Takenobu Soma. Their collaborative efforts have further enhanced the research and development initiatives at Takeda.

Conclusion

Tadatsugu Harukawa's innovative work in the field of antibacterial agents highlights his importance as an inventor. His patent for 6-(1'-Cyclohexenylglycinamido)penicillanic acid represents a significant advancement in medical science. His contributions continue to influence the pharmaceutical industry and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…